相关优先结局下广义成对比较的净获益:一项模拟研究
该模拟研究基于广义成对比较(GPC)框架,评估优先结局间相关性对优先净获益(Δ)估计值、偏倚、检验水准和功效的影响。研究针对二分类疗效与二分类毒性、或至事件疗效与分类毒性两种常见情形,在不同相关水平下模拟。结果显示相关性可显著但可预测地改变Δ及其估计值,并影响检验功效,提示样本量估算时应考虑结局相关性。
要点
- 优先结局间的相关性会改变GPC净获益Δ的估计值,但不引入偏倚。
- 正相关主要减少Losses比例,负相关主要减少毒性结局上的Wins比例。
- 临床试验进行样本量估算时,应考虑优先结局之间的相关性。
核心结论
- 优先结局间的相关性对GPC分析的Δ及其估计值产生显著但可预测的影响,并可能改变检验功效。
研究设计与样本
- 模拟研究,基于广义成对比较(GPC)框架评估优先结局间相关性对Δ估计值、偏倚、检验水准和功效的影响。
- 模拟两种常见情形:二分类疗效结局合并二分类毒性结局,或至事件疗效结局合并分类毒性结局,并设置不同相关水平。
- 理论Δ值在两种相关二分类结局且使用正态Copula的特定情形下推导。
主要发现
- 当试验组疗效优于对照组时,正相关主要与Losses比例下降相关,负相关主要与毒性结局上Wins比例下降相关。
- Δ估计值随正相关强度增加而增大,且不引入偏倚。
- 不同结局类型下结果相似,但相关性会导致检验功效改变。
临床怎么用
- 在基于GPC的临床试验设计中,进行样本量估算时应考虑优先结局间的相关性。
- 解读GPC净获益结果时,需注意结局相关性可能影响Δ估计值和检验功效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prioritized net benefit (Δ) is a measure of the benefit-risk balance in clinical trials, based on generalized pairwise comparisons (GPC) using several prioritized outcomes. Its estimation requires the classification as Wins or Losses of all possible pairs of patients, one from the experimental treatment (E) group and one from the control treatment (C) group. In this simulation study, we assessed the impact of the correlation between prioritized outcomes on Δ, its estimate, bias, size, and power. METHODS: The theoretical Δ value was derived for the specific case of two correlated binary outcomes when a normal copula is used. Focusing on one efficacy and one toxicity outcome, two situations frequently met in practice were simulated: binary efficacy outcome with binary toxicity outcome, or time to event efficacy outcome with categorical toxicity outcome. Several scenarios of efficacy and toxicity were generated, with various levels of correlation. RESULTS: When E was more effective than C, positive correlations were mainly associated with a decrease in the proportion of Losses, while negative correlations were associated with a decrease in the proportion of Wins on the toxicity outcome. This resulted in an increase of Δ^ with the intensity of the positive correlation without adding any bias. Results were similar whatever the type of outcomes generated but led to power alteration. CONCLUSION: Correlations between outcomes analyzed with GPC led to substantial but predictable modifications of Δ and its estimate. Correlations should be taken into consideration when performing sample size estimations in clinical trials.
引用
- Giai J, Maucort-Boulch D, Ozenne B, et al. Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study. Stat Med. 2020. PMID: 33140505. doi:10.1002/sim.8788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。